Atara Biotherapeutics, INC. (ATRA) — SC 13G/A Filings

All SC 13G/A filings from Atara Biotherapeutics, INC.. Browse 14 SC 13G/A reports with AI-powered summaries and risk analysis.

SC 13G/A Filings (14)

SC 13G/A Filing — Nov 14, 2024
SC 13G/A Filing — Nov 14, 2024
SC 13G/A Filing — Nov 12, 2024
SC 13G/A Filing — Nov 4, 2024
SC 13G/A Filing — Sep 13, 2024
SC 13G/A Filing — Jul 8, 2024
SC 13G/A Filing — Feb 14, 2024
SC 13G/A Filing — Feb 14, 2024
SC 13G/A Filing — Feb 13, 2024
Wasatch Advisors LP Divests Entire Stake in Atara Biotherapeutics — Feb 9, 2024 Risk: medium
Wasatch Advisors LP, an investment adviser, filed an amended SC 13G/A on February 9, 2024, indicating they no longer hold any shares of Atara Biotherapeutics, I
Goldman Sachs Amends Atara Bio Stake on Dec 29 — Feb 6, 2024
Goldman Sachs Group Inc. filed an amended SC 13G/A on February 6, 2024, indicating a change in their beneficial ownership of Atara Biotherapeutics, Inc. common
BlackRock Amends Atara Bio Stake, Signals Portfolio Adjustment — Jan 26, 2024
BlackRock Inc. filed an amended Schedule 13G/A on January 26, 2024, indicating a change in its ownership of Atara Biotherapeutics, Inc. common stock as of Decem
State Street Corp. Updates Passive Stake in Atara Biotherapeutics — Jan 22, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 22, 2024, indicating its ownership of Atara Biotherapeutics Inc. c
Baupost Group Slashes Atara Bio Stake to 10.7% from 19.9% — Jan 9, 2024
Baupost Group LLC/MA, a major investment firm, has updated its ownership stake in Atara Biotherapeutics, Inc. (ATRA) as of December 31, 2023. This Amendment No.

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX